Condition 1: Type 2 Diabetes. Condition 2: Non-alcoholic fatty liver. Type 2 diabetes mellitus Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Yoga exercise group: This group performed cyclic yoga exercise for two months, three days a week. Cyclic Yoga is the art of sequencing yoga asana, pranayama and mu
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 55 Years
Inclusion criteria
Inclusion criteria: Type 2 diabetic women with Non-alcoholic fatty liver disease Type 2 diabetic women 45 to 55 years old with overweight
Exclusion criteria
Exclusion criteria: No insulin treatment No complications of diabetes (neuropathy, nephropathy, retinopathy) No use of drugs and alcoholic drinks, Not participating in regular exercise activities No history of cardiovascular and mental illness No history of fractures, surgery or joint diseases, Three times or more Absence in training sessions Lack of hormone therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycosylated Hemoglobin. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with Pishtaz Teb kit.;Fasting blood glucose. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;Fatty liver grade. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Alanine Aminotransferase enzyme. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;Aspartate Aminotransferase enzyme. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;Alkaline phosphatase enzyme. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;LDL Cholesterol. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;HDL Cholesterol. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;Cholesterol. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with BioSystems kit.;Insulin Hormone. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test Siemens kit made in America.;Waist Circumference. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Standard tape meter.;Blood Pressure. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: brachial digital blood pressure monitor.;IGF-1 Hormone. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention. Method of measurement: Blood test with DiaSorin kit | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Bayat
University of Tehran
Outcome results
None listed